Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Emerging Technology in Neuroendocrine Imaging

  • You have access
    68Ga-DOTANOC PET-CT in restaging gastrointestinal neuroendocrine tumors after primary treatment: A single institutional experience
    Sumeet Malapure, Varun Dhull, Punit Sharma, Girish Parida, Chandrashekhar Bal and Rakesh Kumar
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 270;
  • You have access
    Higher sensitivity of 68Ga-DOTATOC PET/CT compared with 111In-pentetreotide scan with SPECT/CT in neuroendocrine tumors
    Inki Lee, Min Young Yoo, Jin Chul Paeng, Gi Jeong Cheon, Dong Soo Lee, June-Key Chung and Keon Wook Kang
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 268;
  • You have access
    A somatostatin receptor-density surrogate derived from Ga-DOTATOC PET and contrast enhanced MRI as a response predicting parameter in liver metastasized neuroendocrine tumors prior to PRRT
    Matthäus Cieciera, Clemens Kratochwil, Paul Flechsig, Uwe Haberkorn and Frederik Giesel
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 269;
  • You have access
    Scandium-44 DOTATOC PET/CT: First in-human molecular imaging of neuroendocrine tumors and possible perspectives for Theranostics
    Aviral Singh, Richard Baum, Ingo Klette, Nick van der Meulen, Cristina Mueller, Andreas Tuerler and Roger Schibli
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 267;
  • You have access
    Role of 99mTc-Tektrotyd SPECT-CT in patients with pulmonary neuroendocrine tumors (NETs)
    Sonya Sergieva
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 271;
  • You have access
    First clinical data on 68Ga-labeled somatostatin receptor antagonists: a phase I/II study comparing 68Ga-OPS202 with 68Ga-DOTATOC PET/CT.
    Guillaume Nicolas, Felix Kaul, Ramon Mena, Hakim Bouterfa, Melpomeni Fani and Damian Wild
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 266;
  • You have access
    Superiority of [68Ga]-DOTATATE PET/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma
    Ingo Janssen, Elise Blanchet, Clara Chen, Corina Millo, Peter Herscovitch, David Taieb, Electron Kebebew, Hendrik Lehnert, Antonio Fojo and Karel Pacak
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 265;
SNMMI

© 2025 SNMMI

Powered by HighWire